Professor of Medicine, SUNY Stony Brook
Oncology
Dr. Stefan Madajewicz, MD
|
|
Give Review
Dr. Stefan Madajewicz is an expert in the field of Oncology. He went to New York Medical College - Metropolitan Hospital Center. Doctor Stefan Madajewicz, MD is a published doctor and has 65 publications published. The lastest was: 'Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.'
Publications
- Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel Analyses from two large, randomised, phase III trials.
- Phase I chemotherapy study of biochemical modulation of folinic acid and fluorouracil by gemcitabine in patients with solid tumor malignancies.
- Therapy for patients with high grade Astrocytoma using intraarterial chemotherapy and radiation therapy.
- Actual 5-year survival of patients with stage IIIB Breast carcinoma: phase II trial of methotrexate, vinblastine, adriamycin, cisplatin, and folinic acid.
- Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with Brain tumors.
- Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.
- Positron emission tomography study of human prostatic adenoCarcinoma using carbon-11 putrescine.
- Efficacy and tolerability of Oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance o...
- Preclinical and clinical evaluation of 5-fluorouracil biochemical modulation with folinic acid and hydroxyurea for patients with coloRectal carcinoma.
- Treatment of Cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone.
- Alpha interferon, leucovorin, and 5-fluorouracil (ALF) in advanced Cancer: results of a dose-finding study and evidence of activity in non-small cell lung Cancer.
- Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases.
- Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.
- Chemotherapy of advanced, hormonally resistant prostatic Carcinoma.
- Diamminodichloroplatinum combination chemotherapy in non-oat cell Carcinoma of the lung.
- Cisplatin combination chemotherapy in non-oat cell Carcinoma of the lung.
- Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced Cancer.
- Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP).
- Phase I-II diaziquone chemotherapy in Brain tumors.
- Malignant melanoma Brain metastases. Review of Roswell Park Memorial Institute experience.
- Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal Cancer.
- Phase II study--intra-arterial BCNU therapy for metastatic Brain tumors.
- Hypothalamo-pituitary-Adrenal axis in patients with prostatic carcinoma.
- New potential treatment modalities for disseminated prostatic Cancer.
- [Preliminary investigations on the citric acid concentration serum of patients with rheumatoid conditions].
- Comparative ultrafiltrability of calcium and strontium in human plasma.
- [Serum proteins and electrolytes in patients with Cancer of the uterus].
- [Spindle-cell variety of cervical Cancer (carcinoma fusocellulare colli uteri)].
- [Hypermagnesiemia in some neoplastic Disorders].
- [Studies of the relationship between Anemia and the results of therapy of patients with cervix carcinoma].
- Hypermagnesemia in Malignant neoplasms.
- [Changes in blood proteins and electrolyte patterns in patients with cervical Carcinoma during treatment with ionizing radiations].
- [The functional state of the pituitary-Adrenal system in carcinoma of the cervix].
- Calcium metabolism after castration.
- Human pharmacokinetics of 1-[2-[2-(4 pyridyl)-2-imidazolinyl-(1)]-ethyl]-3-(4-carboxyphenyl) urea (CGP 15720A).
- Evaluation of the nephrotoxicity of iproplatin (CHIP) in comparison to cisplatin by the measurement of urinary enzymes.
- Effect of renal function impairment of iproplatin pharmacokinetics and relation to toxicity.
- Phase-I clinical trial of sodium cyanate in patients with advanced coloRectal carcinoma.
- Clinical development of iproplatin (CHIP).
- Phase I clinical trial of 1-(2-[2-(4-pyridyl)-2-imidazoline-1-yl]-ethyl)-3-(4-carboxy-phenyl) urea (CGP 15720A).
- Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic coloRectal adenocarcinoma.
- Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809).
- A promising regimen for stage IIIB breast Cancer.
- Clinical experience with 5-FU/DDP +/- OHDW combination chemotherapy in patients with advanced coloRectal carcinoma.
- Phase I clinical trial and human pharmacokinetics of 2,4-diamino-5-adamantyl-6-methyl pyrimidine ethane sulfonate (DAMP-ES): a lipid-soluble antifolate.
- Intravenous sedation during hepatic artery chemotherapeutic embolization.
- Randomized phase II evaluation of carboplatin and CHIP in advanced transitional cell Carcinoma of the urothelium. The Eastern Cooperative Oncology Group.
- Management of metastases-induced Acute pancreatitis in small cell carcinoma of the lung.
- Clinical trials with 5-fluorouracil, folinic acid and cisplatin in patients with gastrointestinal malignancies.
- Intracarotid chemotherapy with etoposide and cisplatin for malignant Brain tumors.
- Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of...
- Insulin-induced growth hormone response in patients with uterus Carcinoma. I. Endometrial Carcinoma.
- Carcinoembryonic antigen as a monitor of successful surgical resection in 130 patients with Carcinoma of the lung.
- Prednimustine therapy for advanced prostatic Cancer.
- Insulin-induced growth hormone responses in patients with prostatic Carcinoma.
- Estramustine. Metabolic pattern and possible mechanisms for its action in prostate Cancer.
- Prostatic Cancer. Immunochemical detection of prostatic acid phosphatase in serum and bone marrow.
- Steroid hormone receptors in the Prostate.
- Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplati...
- Abdominal aortitis after use of granulocyte colony-stimulating factor.
- Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast Cancer patients.
- A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung Cancer: an Eastern Cooperative Oncology Grou...
- A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplati...
- Implication of delayed TNF-alpha exposure on dendritic cell maturation and expansion from cryopreserved cord blood CD34+ hematopoietic progenitors.
Schools
Medical University of Warsaw
Temple University Hospital
University At Buffalo State University Of New York
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
New York Medical College - Metropolitan Hospital Center -
Medical University of Warsaw
Helpful Reviews
Similar Doctors
|
|
Dr. Sunny K. Philip Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janice M. Lu, MD |
|
|
Dr. Shenhong Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamara Weiss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amna F. Sher, MD |